source
- Opinion: MAHA and insurance companies both want to treat human bodies like cars“If the short history of telematics in the auto insurance taught us anything, it’s to be skeptical of any promises attached to shareable surveillance data.”STAT · 31m ago↗ source
- Neurocrine’s rare-disease drug approved but later linked to deaths and serious side effectsNeurocrine Biosciences received regulatory approval for a rare‑disease therapy after a small clinical trial showed modest efficacy and side effects that were considered manageable. The decision was…